Stay updated on Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.

Latest updates to the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check11 days agoChange DetectedRecent updates include new entries for January 2025, while previous updates from September 2024 have been removed.SummaryDifference0.9%
- Check18 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check25 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check54 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check61 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference3%
Stay in the know with updates to Entinostat + Pembrolizumab in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat + Pembrolizumab in Lymphomas Clinical Trial page.